Global Dialysis - Merck Dumps Heplisav in Wake of Regulatory Issues

Merck Dumps Heplisav in Wake of Regulatory Issues - TMCnet

The clinical hold halted progress with Dynavax's Phase II trial in ESRD and consistency studies needed for the healthy adult biologics license application. ...